Literature DB >> 12965946

Preventing infectious diseases during and after international adoption.

Lin H Chen1, Elizabeth D Barnett, Mary E Wilson.   

Abstract

Families of internationally adopted children face risks associated with travel if they pick up their children overseas. Unlike other travelers, they also face risks because of close contact with a child with uncertain infection and vaccination status. Tuberculosis organisms, hepatitis A virus, hepatitis B virus, and measles virus have been transmitted from adopted children to family and community members. Intestinal parasites, Bordetella pertussis, and other infectious disease agents can also be transmitted. Some of these infections may be inapparent or may not manifest in adopted children until many years after the adoption. Increased attention to preventive measures for family members and early diagnosis of infectious diseases in adopted children can reduce transmission of the organisms causing these infections. Those providing health care to families planning international adoption should know about standard pretravel advice, as well as the spectrum of possible infections in adopted children, so that they can protect the health of the travelers and family members and close friends who will welcome the new child into the home.

Entities:  

Mesh:

Year:  2003        PMID: 12965946     DOI: 10.7326/0003-4819-139-5_part_1-200309020-00013

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  10 in total

1.  Statement on International Adoption: Committee to Advise on Tropical Medicine and Travel.

Authors:  C Hui; S Kuhn; H MacDonnell
Journal:  Can Commun Dis Rep       Date:  2010-12-01

2.  SHV-12-like extended-spectrum-beta-lactamase-producing strains of Salmonella enterica serotypes Babelsberg and Enteritidis isolated in France among infants adopted from Mali.

Authors:  François-Xavier Weill; Marie Demartin; Didier Tandé; Emmanuelle Espié; Ignace Rakotoarivony; Patrick A D Grimont
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  Transmission of multiple resistant Salmonella Concord from internationally adopted children to their adoptive families and social environment: proposition of guidelines.

Authors:  R Vanhoof; P Gillis; O Stévart; C Boland; O Vandenberg; F Fux; J-M Collard; S Bertrand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-10       Impact factor: 3.267

Review 4.  Dermatologic conditions in internationally adopted children.

Authors:  Diane L Whitaker-Worth; Cheryl B Bayart; Julia Anderson Benedetti
Journal:  Int J Womens Dermatol       Date:  2015-03-02

5.  Infectious diseases prevalence, vaccination coverage, and diagnostic challenges in a population of internationally adopted children referred to a Tertiary Care Children's Hospital from 2009 to 2015.

Authors:  Sara Sollai; Francesca Ghetti; Leila Bianchi; Maurizio de Martino; Luisa Galli; Elena Chiappini
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 6.  International adoption: issues in infectious diseases.

Authors:  Dana D Staat; Michael E Klepser
Journal:  Pharmacotherapy       Date:  2006-09       Impact factor: 4.705

7.  Prevention of travel-related infectious diseases in families of internationally adopted children.

Authors:  Elizabeth D Barnett; Lin H Chen
Journal:  Pediatr Clin North Am       Date:  2005-10       Impact factor: 3.278

Review 8.  Importation and Transmission of Parasitic and Other Infectious Diseases Associated with International Adoptees and Refugees Immigrating into the United States of America.

Authors:  Jordan Smith Darr; David Bruce Conn
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

9.  Acute care issues in internationally adopted children.

Authors:  Julia Kim; Mary Allen Staat
Journal:  Clin Pediatr Emerg Med       Date:  2004-05-10

10.  Role of immigrants and migrants in emerging infectious diseases.

Authors:  Elizabeth D Barnett; Patricia F Walker
Journal:  Med Clin North Am       Date:  2008-11       Impact factor: 5.456

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.